Production of a recombinant vaccine candidate against Burkholderia pseudomallei exploiting the bacterial N-glycosylation machinery.
about
Recombinant expression of Streptococcus pneumoniae capsular polysaccharides in Escherichia coli.Regulatory potential of post-translational modifications in bacteria.The sweet branch of metabolic engineering: cherry-picking the low-hanging sugary fruitsEngineering and Dissecting the Glycosylation Pathway of a Streptococcal Serine-rich Repeat AdhesinDeciphering minimal antigenic epitopes associated with Burkholderia pseudomallei and Burkholderia mallei lipopolysaccharide O-antigens.Increased efficiency of Campylobacter jejuni N-oligosaccharyltransferase PglB by structure-guided engineering.Melioidosis and glanders modulation of the innate immune system: barriers to current and future vaccine approaches.Expression of Glycosylated Proteins in Bacterial System and Purification by Affinity Chromatography.Vaccines for the Prevention of Melioidosis and Glanders.Potential targets for next generation anti-microbial glycoconjugate vaccines.Production and efficacy of a low-cost recombinant pneumococcal protein polysaccharide conjugate vaccine.A recombinant conjugated pneumococcal vaccine that protects against murine infections with a similar efficacy to Prevnar-13Structure of bacterial oligosaccharyltransferase PglB bound to a reactive LLO and an inhibitory peptide
P2860
Q27336832-F42C8EC9-501B-41E2-B8A2-86B289B192E4Q35659128-875FB68C-346B-4C2B-9E2D-B91F6BE3BBA5Q36361549-A2609F9A-FEC5-403F-B87A-5CC51FB8A56AQ37551411-6BC809FB-F2F8-4842-8600-CA7625852067Q38287677-8A86030A-C08C-4FC1-9753-2079A2C0C625Q38300058-EBD291CD-1F69-4DE8-848E-99646408E423Q38890754-D12D3E1E-DD5F-4BE2-AFA7-CD9F5B8C4704Q47786845-D99703F2-A474-4796-8509-BC2DAC379F38Q49834322-E73FC725-8E77-498C-B401-27E8A4757228Q53701548-0EF5B043-0E68-4E5A-B1A6-7595EBD86DD3Q55310096-384B3F8A-41A0-436E-BC83-393F28C6CD5AQ58587115-B60F9132-1457-45BD-BAF8-E999E6C9051EQ58618197-9BED273A-1C36-4AB4-B5D5-508A9CBE1880
P2860
Production of a recombinant vaccine candidate against Burkholderia pseudomallei exploiting the bacterial N-glycosylation machinery.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Production of a recombinant va ...... ial N-glycosylation machinery.
@ast
Production of a recombinant va ...... ial N-glycosylation machinery.
@en
type
label
Production of a recombinant va ...... ial N-glycosylation machinery.
@ast
Production of a recombinant va ...... ial N-glycosylation machinery.
@en
prefLabel
Production of a recombinant va ...... ial N-glycosylation machinery.
@ast
Production of a recombinant va ...... ial N-glycosylation machinery.
@en
P2093
P2860
P356
P1476
Production of a recombinant va ...... rial N-glycosylation machinery
@en
P2093
Chad Stratilo
Fatima Garcia-Quintanilla
Jeremy A Iwashkiw
Nancy L Price
P2860
P356
10.3389/FMICB.2014.00381
P577
2014-07-29T00:00:00Z